Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial.
Saved in:
| Title: | Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial. |
|---|---|
| Authors: | Montejano R; Infectious Diseases Unit, Internal Medicine Department, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain., de la Calle-Prieto F; Infectious Diseases Unit, Internal Medicine Department, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain., Velasco M; Infectious Diseases, Research Unit, University Hospital Fundación Alcorcón, Madrid, Spain., Guijarro C; Internal Medicine Unit, University Hospital Fundación Alcorcón, Rey Juan Carlos University, Madrid, Spain., Queiruga-Parada J; Clinical Pharmacology Department, La Paz University Hospital, Infectious Diseases Unit, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, Madrid, Spain., Jiménez-González M; Clinical Pharmacology Department, La Paz University Hospital, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, Spanish Clinical Research Network, Madrid, Spain., González-Ruano P; Internal Medicine Department, University Hospital Infanta Sofía, Madrid, Spain., Martínez P; Internal Medicine Department, University Hospital Infanta Sofía, Madrid, Spain., Goikoetxea AJ; Infectious Diseases Unit, Cruces University Hospital, Barakaldo, Spain., Ibarrola M; Infectious Diseases Unit, Cruces University Hospital, Barakaldo, Spain., Ciudad M; Infectious Diseases Unit, Internal Medicine Department, La Princesa University Hospital, Madrid, Spain., Gutiérrez Á; Infectious Diseases Unit, Internal Medicine Department, La Princesa University Hospital, Madrid, Spain., Torralba M; Internal Medicine Department, Guadalajara University Hospital, University of Alcalá, Spain., Díaz-Brasero A; Internal Medicine Department, Guadalajara University Hospital, University of Alcalá, Spain., Ryan P; Infanta Leonor University Hospital, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, School of Medicine, Complutense University, Madrid, Spain., Marcelo C; Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain., Díez C; Clinical Microbiology and Infectious Diseases Department, Gregorio Marañón University Hospital, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Ibarra S; Infectious Diseases Department, Basurto University Hospital, Basurto, Spain., Merino E; Infectious Diseases Unit, Alicante General University Hospital, Alicante Institute of Health and Biomedical Research, Alicante, Spain., Estrada V; Infectious Diseases Unit, Internal Medicine Department, Clínico San Carlos University Hospital, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain., Marcos J; Internal Medicine Department, University Hospital Fundación Alcorcón, Madrid, Spain., Novella M; Internal Medicine Department, Príncipe de Asturias University Hospital, Alcalá de Henares, Spain., Rivera MA; Emergency Department, La Paz University Hospital, Madrid, Spain., Ruiz-Muñoz M; Internal Medicine Department, University Hospital Fundación Alcorcón, Madrid, Spain., de Miguel M; Fundación SEIMC-GESIDA, Madrid, Spain., Soler L; Internal Medicine Department, University Hospital Infanta Sofía, Madrid, Spain., Del Álamo M; Infectious Diseases Unit, Cruces University Hospital, Barakaldo, Spain., Moreno S; Infectious Diseases Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria, University of Alcalá School of Medicine, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain., Carcas AJ; Clinical Pharmacology Department, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, School of Medicine, Autonomous University of Madrid, Spanish Clinical Research Network, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, School of Medicine, Autonomous University of Madrid, Spanish Clinical Research Network, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain., Arribas JR; Infectious Diseases Unit, Internal Medicine Department, La Paz University Hospital, Instituto de Investigación del Hospital Universitario La Paz, School of Medicine, Autonomous University of Madrid, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain. |
| Corporate Authors: | PANCOVID Study Group |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Feb 08; Vol. 76 (3), pp. e116-e125. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't; Pragmatic Clinical Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciac628 |
